pre-IPO PHARMA

COMPANY OVERVIEW

Curtana Pharmaceuticals is developing highly targeted therapies for the treatment of brain cancer, including glioblastoma in adults and pediatric high grade glioma in children.


LOCATION

  • Austin, TX, USA
  • London, , UK

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.curtanapharma.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    angelmd biosense-global defta-partners thynk-capital


    PRESS RELEASES


    Aug 16, 2017

    Halloran Consulting Group Announces Role as US Regulatory Lead for Curtana Pharmaceuticals’ CT-179 Orphan Drug Designation for the Treatment of Gliomas


    For More Press Releases


    Google Analytics Alternative